Tumour-necrosis-factor antibody treatment in Crohn's disease
- 17 July 1993
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 342 (8864), 173-174
- https://doi.org/10.1016/0140-6736(93)91375-v
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Enhanced mucosal cytokine production in inflammatory bowel diseaseGastroenterology, 1992
- Tumour necrosis factor alpha in stool as a marker of intestinal inflammationThe Lancet, 1992
- Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.Gut, 1992
- Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.Gut, 1991